>
SQI Diagnostics Inc logo

SQD - SQI Diagnostics Inc Share Price

C$0.255 0.0  0.0%

Last Trade - 11/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £53.8m
Enterprise Value £53.8m
Revenue £571k
Position in Universe 898th / 2705
Bullish
Bearish
Unlock SQD Revenue
Momentum
Relative Strength (%)
1m -27.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -50.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.44 1.42 0.97 1.34 1.89 1.02 +18.2%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 December 2020, SQIDiagnostics Inc. revenues decreased 22% to C$161K. Net lossincreased 85% to C$3.7M. Revenues reflect Product salesdecrease of 29% to C$104K, Services revenue decrease of 5%to C$57K. Higher net loss reflects Stock based compensationincrease from C$50K to C$873K (expense), Laboratory costand supplies increase from C$228K to C$870K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

SQD Revenue Unlock SQD Revenue

Net Income

SQD Net Income Unlock SQD Revenue

Normalised EPS

SQD Normalised EPS Unlock SQD Revenue

PE Ratio Range

SQD PE Ratio Range Unlock SQD Revenue

Dividend Yield Range

SQD Dividend Yield Range Unlock SQD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
SQD EPS Forecasts Unlock SQD Revenue
Profile Summary

SQI Diagnostics Inc (SQI) is a Canada-based diagnostics company. The Company develops multiplexed tests and automated systems for customers needing to measure a range of biomarkers in blood or other common sample types. It offers three different platforms sqidlite, sqid x and the siqdworks to run and analyze its microarray plates. Its Ig_plex microarrays have the ability to discriminate between individual isotypes of antibodies and antigens and proteins within a single well of a microarray. Its Ig_plex CHEX technology provides multiple in-microarray checks. It has three areas of focus: Testing for the drug development industry, Animal health testing, Human disease testing or deoxyribonucleic acid (DNA) diagnostic testing. In drug development testing, SQI provides technology and equipment for blood testing in clinical trials and pre-clinical research for developing various drugs. It applies its multiplexing technology to diagnostic tests used for customers in the animal health segment.

Directors
Last Annual September 30th, 2020
Last Interim December 31st, 2020
Incorporated September 11, 2003
Public Since February 9, 2005
No. of Shareholders: n/a
No. of Employees: 37
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange TSX Venture Exchange
Shares in Issue 340,694,992
Free Float (0.0%)
Eligible for
ISAs
SIPPs
SQD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for SQD
Upcoming Events for SQD
Wednesday 26th May, 2021 Estimate
Q2 2021 SQI Diagnostics Inc Earnings Release
Wednesday 25th August, 2021 Estimate
Q3 2021 SQI Diagnostics Inc Earnings Release
Frequently Asked Questions for SQI Diagnostics Inc
What is the SQI Diagnostics Inc share price?

As of 11/05/21, shares in SQI Diagnostics Inc are trading at C$0.255, giving the company a market capitalisation of £53.8m. This share price information is delayed by 15 minutes.

How has the SQI Diagnostics Inc share price performed this year?

Shares in SQI Diagnostics Inc are currently trading at C$0.255 and the price has moved by 50% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the SQI Diagnostics Inc price has moved by 15.29% over the past year.

What are the analyst and broker recommendations for SQI Diagnostics Inc?

Of the analysts with advisory recommendations for SQI Diagnostics Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for SQI Diagnostics Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will SQI Diagnostics Inc next release its financial results?

SQI Diagnostics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the SQI Diagnostics Inc dividend yield?

SQI Diagnostics Inc does not currently pay a dividend.

Does SQI Diagnostics Inc pay a dividend?

SQI Diagnostics Inc does not currently pay a dividend.

When does SQI Diagnostics Inc next pay dividends?

SQI Diagnostics Inc does not currently pay a dividend.

How do I buy SQI Diagnostics Inc shares?

To buy shares in SQI Diagnostics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of SQI Diagnostics Inc?

Shares in SQI Diagnostics Inc are currently trading at C$0.255, giving the company a market capitalisation of £53.8m.

Where are SQI Diagnostics Inc shares listed? Where are SQI Diagnostics Inc shares listed?

Here are the trading details for SQI Diagnostics Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: SQD
What kind of share is SQI Diagnostics Inc?

Based on an overall assessment of its quality, value and momentum, SQI Diagnostics Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a SQI Diagnostics Inc share price forecast 2021?

We were not able to load any forecast data for SQI Diagnostics Inc.

How can I tell whether the SQI Diagnostics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SQI Diagnostics Inc. Over the past six months, the relative strength of its shares against the market has been -12.15%. At the current price of C$0.255, shares in SQI Diagnostics Inc are trading at -5.84% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the SQI Diagnostics Inc PE Ratio?

We were not able to find PE ratio data for SQI Diagnostics Inc.

Who are the key directors of SQI Diagnostics Inc?

SQI Diagnostics Inc's management team is headed by:

Claude Ricks - IND
Andrew Morris - DRC
Clive Beddoe - IND
Gerald Connor - IND
Wilmot Matthews - IND
Eric Brouwer - CSO
Robert Chioini - CEO
Who are the major shareholders of SQI Diagnostics Inc?

Here are the top five shareholders of SQI Diagnostics Inc based on the size of their shareholding:

Matthews (Wilmot Leslie) Individual Investor
Percentage owned: 25.52% (86.9m shares)
Cumberland Private Wealth Management Inc. Investment Advisor
Percentage owned: 25.16% (85.7m shares)
Beddoe (Clive J) Individual Investor
Percentage owned: 25.12% (85.6m shares)
Connor (Gerald R) Individual Investor
Percentage owned: 4.46% (15.2m shares)
Next Edge Bio-Tech Plus Class Hedge Fund Portfolio
Percentage owned: 1.2% (4.10m shares)
Similar to SQD
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.